Dova Pharmaceuticals reports 2018 executive compensation

CFO Mark W. Hahn receives $5.1M

Dova Pharmaceuticals reported fiscal year 2018 executive compensation information on March 15, 2019.

In 2018, four executives at Dova Pharmaceuticals received on average a compensation package of $2,831,161, a 11% decrease compared to previous year.

Average pay of disclosed executives at Dova Pharmaceuticals

Mark W. Hahn, Chief Financial Officer, received $5,107,445 in total. 92.83% of Hahn's compensation, or $4,741,177, was in option awards. Hahn also received $358,854 in salary and $7,414 in other compensation.

David S. Zaccardelli, Chief Executive Officer, received a compensation package of $4,376,857. 88.34% of the compensation package, or $3,866,442, was in option awards.

Kevin Laliberte, Senior Vice President, Product Development, earned $1,428,227 in 2018.

Alex Sapir, Chief Executive Officer, received $412,113 in 2018, which decreases by 93% compared to 2017.